Cite
Increased circulating Lin(-/low) CD33(+) HLA-DR(-) myeloid-derived suppressor cells in hepatocellular carcinoma patients
MLA
Peng, Shen, et al. “Increased Circulating Lin(-/Low) CD33(+) HLA-DR(-) Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients.” Hepatology Research : The Official Journal of the Japan Society of Hepatology, vol. 44, no. 6, July 2012. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........f515b23a634bb57518998ad6c8881d4f&authtype=sso&custid=ns315887.
APA
Peng, S., Aijuan, W., Mengye, H., Qingqing, W., & Shusen, Z. (2012). Increased circulating Lin(-/low) CD33(+) HLA-DR(-) myeloid-derived suppressor cells in hepatocellular carcinoma patients. Hepatology Research : The Official Journal of the Japan Society of Hepatology, 44(6).
Chicago
Peng, Shen, Wang Aijuan, He Mengye, Wang Qingqing, and Zheng Shusen. 2012. “Increased Circulating Lin(-/Low) CD33(+) HLA-DR(-) Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients.” Hepatology Research : The Official Journal of the Japan Society of Hepatology 44 (6). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........f515b23a634bb57518998ad6c8881d4f&authtype=sso&custid=ns315887.